Organism name | Prunus cerasus |
---|---|
Genus | Prunus |
Family | Rosaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Prunus cerasus |
---|---|
Linked NCBI taxonomy ID | 140311 |
Linked level | species |
Family in NCBI taxonomy | Rosaceae |
---|---|
ID | 3745 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | rosids |
---|---|
ID | 71275 |
Species | Activity |
---|---|
Prunus cerasus L. | Analgesic |
Prunus cerasus L. | Anticancer |
Prunus cerasus L. | Antiinflammatory |
Prunus cerasus L. | Antioxidant |
Prunus cerasus L. | Antipyretic |
Prunus cerasus L. | Apoptotic |
Prunus cerasus L. | Astringent |
Prunus cerasus L. | Diuretic |
Prunus cerasus L. | Hematonic |
Prunus cerasus L. | Pectoral |
Prunus cerasus L. | Sedative |
Prunus cerasus L. | Tonic |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00002376
![]() |
Cyanidin 3-rutinoside
|
CHEMBL505251
|
C020386
|
3 / 0 / 1 | No. 1 | No. 15 |
![]() |
|
C00005194
![]() |
Kaempferol 3,4'-diglucoside
/ Kaempferol 3,4'-di-O-beta-D-glucopyranoside / 3-(beta-D-Glucopyranosyloxy)-2-[4-(beta-D-glucopyranosyloxy)phenyl]-5,7-dihydroxy-4H-1-benzopyran-4-one |
CHEMBL2206208
|
No. 1 | No. 15 |
![]() |
|||
C00006658
![]() |
Cyanidin 3-sophoroside
|
No. 1 | No. 15 |
![]() |
||||
C00006660
![]() |
Cyanidin 3-gentiobioside
|
No. 1 | No. 15 |
![]() |
||||
C00006680
![]() |
Peonidin galactoside
/ Peonidin 3-galactoside / Peonidin 3-O-beta-D-galactopyranoside |
CHEMBL1784263
|
No. 2 | No. 15 |
![]() |
|||
C00010162
![]() |
Genistein 5-O-glucoside
|
No. 2 | No. 15 |
![]() |
||||
C00010167
![]() |
Prunetinoside
/ Prunetin 5-O-glucoside |
No. 2 | No. 15 |
![]() |
||||
C00002374
![]() |
Chrysanthemin
/ Cyanidin 3-O-glucoside |
CHEMBL257839
CHEMBL1197952 |
C114438
|
1 / 0 / 1 | No. 2 | No. 15 |
![]() |
|
C00013313
![]() |
Isothymusin
/ 5,8-Dihydroxy-2-(4-hydroxyphenyl)-6,7-dimethoxy-4H-1-benzopyran-4-one |
CHEMBL487196
|
C487424
|
1 / 0 / 0 | No. 3 | No. 15 |
![]() |
|
C00006671
![]() |
Cyanidin 3-(2G-xylosylrutinoside)
|
No. 5 | No. 15 |
![]() |
||||
C00005488
![]() |
Quercetin 3-rutinoside-7,3'-diglucoside
|
No. 5 | No. 15 |
![]() |
||||
C00008157
![]() |
Dihydrowogonin 7-O-glucoside
|
No. 12 | No. 14 |
![]() |
||||
C00008156
![]() |
Dihydrowogonin
|
No. 25 | No. 14 |
![]() |
||||
C00000087
![]() |
GA87
/ Gibberellin A87 |
No. 40 | No. 41 |
![]() |
||||
C00000295
![]() |
GA95
/ Gibberellin A95 |
No. 40 | No. 41 |
![]() |
||||
C00000086
![]() |
GA86
/ Gibberellin A86 |
No. 40 | No. 41 |
![]() |
||||
C00000044
![]() |
GA44
/ Gibberellin A44 |
No. 40 | No. 41 |
![]() |
||||
C00000020
![]() |
GA20
/ Gibberellin A20 |
No. 40 | No. 41 |
![]() |
||||
C00000032
![]() |
GA32
/ Gibberellin A32 |
No. 40 | No. 41 |
![]() |
||||
C00000030
![]() |
GA30
/ Gibberellin A30 |
No. 40 | No. 41 |
![]() |
||||
C00000003
![]() |
GA3
/ Gibberellin A3 |
CHEMBL513241
CHEMBL566653 CHEMBL1232952 CHEMBL1476967 CHEMBL1487394 |
C007842
|
10 / 18 / 17 | No. 40 | No. 41 |
![]() |
|
C00008557
![]() |
Aromadendrin 4'-methyl ether
|
CHEMBL480655
CHEMBL458480 |
No. 42 | No. 14 |
![]() |
|||
C00008355
![]() |
Cerasinone
|
No. 77 | No. 14 |
![]() |
||||
C00006965
![]() |
Cerasin
|
CHEMBL601679
|
No. 79 |
![]() |
||||
C00006966
![]() |
Cerasidin
|
No. 79 |
![]() |
|||||
C00000025
![]() |
GA25
/ Gibberellin A25 |
No. 187 | No. 41 |
![]() |
||||
C00000019
![]() |
GA19
/ Gibberellin A19 |
C120175
|
No. 187 | No. 41 |
![]() |
|||
C00000096
![]() |
9-Ribosyl-trans-zeatin
/ Zeatin-9-beta-D-ribofuranoside |
No. 989 |
![]() |
|||||
C00000100
![]() |
IAA
/ Indole-3-acetic acid |
CHEMBL82411
|
C030737
|
3 / 0 / 0 | 2 / 1 | No. 1432 | No. 4 |
![]() |
C00000091
![]() |
trans-Zeatin
|
CHEMBL525239
|
D015026
|
2 / 3 / 2 | 0 / 1 | No. 2879 |
![]() |
|
C00000101
![]() |
IAA methyl ester
/ Methyl indole-3-acetate |
No. 4225 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000003 | 1 / 0 |
Q16773 | Kynurenine--oxoglutarate transaminase 1 | Enzyme | C00000100 | 0 / 0 |
P28907 | ADP-ribosyl cyclase 1 | Enzyme | C00002374 | 0 / 1 |
Q07812 | Apoptosis regulator BAX | Unclassified protein | C00002376 | 0 / 1 |
P02545 | Prelamin-A/C | Unclassified protein | C00000003 | 11 / 10 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00000091 | 3 / 2 |
P02768 | Serum albumin | Secreted protein | C00000100 | 0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000003 | 0 / 1 |
P15559 | NAD(P)H dehydrogenase [quinone] 1 | Enzyme | C00013313 | 0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00000003 | 2 / 0 |
O75496 | Geminin | Unclassified protein | C00000003 | 0 / 0 |
Q16611 | Bcl-2 homologous antagonist/killer | Unclassified protein | C00002376 | 0 / 0 |
O43521 | Bcl-2-like protein 11 | Unclassified protein | C00002376 | 0 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00000003 | 0 / 0 |
Q9HBH1 | Peptide deformylase, mitochondrial | Enzyme | C00000100 | 0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000003 | 0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000003 | 1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000003 | 0 / 1 |
P10275 | Androgen receptor | NR3C4 | C00000003 | 3 / 4 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00000091 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00000100
|
405 | ARNT, HIF-1-beta, HIF-1beta, HIF1-beta, HIF1B, HIF1BETA, TANGO, bHLHe2 | aryl hydrocarbon receptor nuclear translocator |
C00000100
|
OMIM | preferred title | UniProt |
---|---|---|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#114500 | Colorectal cancer; crc |
P84022
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
KEGG | name | UniProt |
---|---|---|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P28907
(marker)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00020 | Colorectal cancer |
Q07812
(related)
|